Cargando…
Protocol Design and Performance Benchmarks by Phase and by Oncology and Rare Disease Subgroups
BACKGROUND: Benchmark data characterizing protocol design practices and performance informs clinical trial design decisions and serves as important baseline measures for assessing protocol design behaviors and their impact during and post-pandemic. METHODS: Tufts CSDD, in collaboration with a workin...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373886/ https://www.ncbi.nlm.nih.gov/pubmed/35960455 http://dx.doi.org/10.1007/s43441-022-00438-5 |